Retraction
Lipid nanoparticles co-loaded with miRNA-22 and methotrexate for enhanced anti-inflammatory response in rheumatoid arthritis
Paper Information
Record ID:
29569
Author(s):
Journal:
Publication Date:
August 18, 2020
Retraction Date:
December 03, 2020
(5.0 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Toxicology Medicine - Immunology Nanotechnology
Biology - Cancer Biology - Cellular Genetics Toxicology Medicine - Immunology Nanotechnology
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Portland Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed
Retraction Details
Citations (2)
2
Total Citations2
Post-Retraction(100.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
632
Days since retraction (latest)
Advances and Perspectives of Pharmaceutical Nanotechnology in mRNA Therapy
Hui Cheng, Zongjin Li
Pharmaceutical Nanotechnology
Published: Aug 2022
632 days after retraction
Combination drug delivery approaches in rheumatoid arthritis
Vanshikha Singh, Afsana Sheikh, Harish Rajak et al. (7 authors)
Elsevier eBooks
Published: Jan 2022
1 citation
1 citation
394 days after retraction
Quick Stats
Total Citations:
2
Years Since Retraction:
5.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025